DRIEHAUS CAPITAL MANAGEMENT INC 13D/13G Filings for Cytokinetics, Incorporated (CYTK)

DRIEHAUS CAPITAL MANAGEMENT INC 13D and 13G filings for Cytokinetics, Incorporated:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
09:42 am
Sale
2021-12-31 13G Cytokinetics, Incorporated
CYTK
DRIEHAUS CAPITAL MANAGEMENT INC 2,327,112
2.770%
-712,144decrease
(-23.43%)
Filing